HKUST and PhIRDA Sign MoU to Establish Innovation Centers
The Hong Kong University of Science and Technology (HKUST) and the China Pharmaceutical Innovation and...
Deals
ClinChoice Acquires Cromsource to Expand Global CRO Footprint
Sino-US Contract Research Organization (CRO) ClinChoice Medical Development has announced the acquisition of Cromsource S.r.l.,...
Echo Biotech Secures Series A++ Funding for Exosomes Drug Development
Echo Biotech, a Beijing-based exosomes drug developer, has reportedly raised “tens of millions” of renminbi...
TinKer Bio Raises Series A+ Funding for Microfluidic Chip Expansion
China-based Hangzhou TinKer BioTechnology Co., Ltd, a leading microfluidic chip technology platform company, has reportedly...
Hexin Medical Technology Raises Series A Funding for Radionuclide Therapy
Hexin Medical Technology Co., Ltd, a radionuclide therapy developer based in Suzhou, has reportedly raised...
Shanghai Pharmaceuticals Partners with Baiyun District for Health Initiative
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has entered into a strategic cooperation agreement...
TandemAI Secures $35M Series A to Expand Drug Discovery Platform
TandemAI, a technology firm with operations in New York, San Diego, and China, has successfully...
Kinnjiu Biopharma Initiates Global Phase I Study for Exarafenib
Shanghai-based Kinnjiu Biopharma Inc. has announced the first subject dosing in the global multi-center Phase...
Pengyang Yiliao Raises Series B+ Funds for Cardiovascular Product Development
Pengyang Yiliao, a Beijing-based developer and manufacturer of cardiovascular technology, has reportedly raised “tens of...
Glowe Raises Series A+ Funding to Expand AIGC in Mental Health
Glowe, an online psychological consultation platform based in Guangdong, has reportedly raised “tens of millions”...
Geneus Tech Secures Funding for Gseq500 Gene Sequencer Production
Geneus Tech, a Shenzhen-based developer and manufacturer of gene sequencers, has reportedly raised an undisclosed...
Alphamab Oncology Partners with Stemirna for BsAb and mRNA Vaccine Development
China-based Alphamab Oncology (HKG: 9966) has announced a strategic partnership with Shanghai-based mRNA drug developer...
BeiGene Reports Outstanding Q4 and Full-Year 2022 Financial Results
BeiGene, Ltd. (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has released financial results for the Q4...
3SBio Terminates Distribution Agreement with AstraZeneca for Byetta
China-based 3SBio Inc. (HKG: 1530) has announced the termination of a distribution agreement with UK...
Topchoice Medical to Acquire 19% Stake in Heren Health for $72.2M
China-based Topchoice Medical Investment Corp., (SHA: 600763) a leading medical service group, is set to...
Eluminex Biosciences Closes $40M Series B for Ophthalmic Innovations
China-based ophthalmic biotech Eluminex Biosciences (Suzhou) Ltd has announced the closure of a Series B...
RinuaGene Raises $14.4M in Pre-Series A+ for mRNA Drug Development
RinuaGene, an mRNA-based drug developer based in Suzhou, has reportedly raised close to RMB 100...
Chipscreen Biosciences Licenses First-in-Class BsAb YH008 from Eucure
China-based biopharma Shenzhen Chipscreen Biosciences Co., Ltd (SHA: 688321) has announced a licensing agreement with...
Suzhou Porton Biologics Partners with CorrGene for Cell and Gene Therapy
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has announced a strategic...
Oricell Therapeutics Closes $45M Series B1 Round for Cellular Immunotherapy
China-based tumor cellular immunotherapeutics developer Oricell Therapeutics Co., Ltd has announced the closing of a...